HCT-15 HT-29 * Figure S1. Oxaliplatin treatment increases CD44high subpopulations in both HCT-15 and HT-29 cells. Flow.

Slides:

Advertisements

Similar presentations

Supplemental Figure cells/ well DLD-1 ALDH+/CD133+ DLD-1 ALDH- /CD133- Supplemental Figure 2.

Advertisements

94Q S Q S 19Q S W1W Q 19Q TAP eluate 94Q S-1 W2 W1 W2 S-1A. Verification of TAP by Western blot (anti-FLAG). S: supernatant of cell lysate.

B Supplementary Fig S1. (A) ZR75- and MCF7-PELP1 knockdown cells were generated as described in methods section. Pooled colonies were analyzed for PELP1.

Supplementary Figure S1.

Supplemental Materials: Anti-apoptotic BCL-2 family proteins as 5-Azacytidine sensitizing targets and determinants of response in myeloid malignancies.

Copyright © 2007 American Medical Association. All rights reserved.

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Hao Zhang, Jing Wei, Rong Xue, Jin-Dan.

B A P-AXL P-AXL AXL AXL P-MET P-MET MET MET P-Akt-473 P-Akt-473 AKT

Supplementary Figure 1 Sensitive Resistant Cell Count Propidium Iodide

Copyright © 2006 American Medical Association. All rights reserved.

Fig. 5. Levels of apoptosis-associated proteins following treatment with parthenolide (PT) and balsalazide. HCT116 cell lysates were prepared after treatment.

The Combined Effects of Hematoporphyrin Monomethyl Ether-SDT and Doxorubicin on the Proliferation of QBC939 Cell Lines Lei Liang, Sheng Xie, Lin Jiang,

Andreas Brown, Johannes Pospiech, Karina Eiwen, Darren J

Supplementary Figure 1 Lapatinib nM mM pEGFR MDA-MB231 EGFR pEGFR

A Untreated mM maphos, 48h 20 mM maphos, 48h 50 mM maphos, 48hh B

Volume 145, Issue 2, Pages (August 2013)

(a) (b) SUPPLEMENTARY FIGURE 1:

Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine

Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR- 181a2 Yanjie Cheng, Zhuying Wei, Shengsong Xie, You Peng, Yi Yan,

Volume 18, Issue 12, Pages (December 2016)

Volume 140, Issue 1, Pages e2 (January 2011)

Volume 141, Issue 2, Pages (August 2011)

Volume 23, Issue 2, Pages (February 2013)

a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)

by Xue Li, Jared Sipple, Qishen Pang, and Wei Du

Volume 120, Issue 6, Pages (March 2005)

Volume 68, Issue 2, Pages e5 (October 2017)

SUPPLEMENTAL TABLE 1. Cell cycle profiles of HeLa cells treated

Drug network derived from the core EGFR interactome and combination strategy to overcome the resistant cells. Drug network derived from the core EGFR interactome.

AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,

Volume 145, Issue 2, Pages (August 2013)

Volume 133, Issue 4, Pages (October 2007)

Volume 9, Issue 5, Pages (November 2017)

Volume 11, Issue 4, Pages (October 2018)

Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells Yangling Li, Miao Xian, Bo Yang, Meidan.

Volume 12, Issue 12, Pages (September 2015)

Volume 12, Issue 2, Pages (August 2003)

Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines:

Volume 21, Issue 3, Pages (March 2012)

BIRC6 confers resistance against cisplatin and oxaliplatin.

Molecular Therapy - Nucleic Acids

Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis Hsin-Su Yu, Gwo-Shing Chen

Volume 127, Issue 4, Pages (October 2004)

Leto et al., Supplementary Figure S3

Volume 7, Issue 6, Pages (December 2016)

The Membrane-Lytic Peptides K8L9 and Melittin Enter Cancer Cells via Receptor Endocytosis following Subcytotoxic Exposure Masayuki Kohno, Tomohisa Horibe,

Activation of GCN2 in UV-Irradiated Cells Inhibits Translation

LAT Links the Pre-BCR to Calcium Signaling

Supplementary Figure 1 A B C SW620 HT29 SW620

Volume 16, Issue 1, Pages (June 2016)

Notch 1 Signaling Regulates Peripheral T Cell Activation

(fold of TGF-β1 response)

pHSF1Ser230 is upregulated by TNF in colon cancer cells.

BCR–ABL kinase activity rewires GM-CSFR signaling and confers oncogene addiction in TF1 cells. BCR–ABL kinase activity rewires GM-CSFR signaling and confers.

The effects of the FASN blocker C75 on cell growth and survival (A, E, and F), on expression/phosphorylation of PI3K and MAPK signaling proteins and on.

The Role of Erk1 and Erk2 in Multiple Stages of T Cell Development

The role of p53 in H2O2-mediated cell death of hOGG1-deficient H1299 lung carcinoma p53 null cells. The role of p53 in H2O2-mediated cell death of hOGG1-deficient.

Identification of NSC as a FADD-kinase inhibitor.

Ultraviolet-B-Induced G1 Arrest is Mediated by Downregulation of Cyclin-Dependent Kinase 4 in Transformed Keratinocytes Lacking Functional p53 Arianna.

Effects of visfatin on the cell proliferation and phosphorylation of ERK, Akt, and GSK-3β proteins in HCC cells. Effects of visfatin on the cell proliferation.

MiR-200c is a PI3K–AKT signaling pathway regulator in CRC

Expression of CRC stem cell markers and L1 in CRC cells.

Ectopic expression of CA RSK1 mutant protects melanoma cells from PD98059-mediated apoptosis. Ectopic expression of CA RSK1 mutant protects melanoma cells.

Immunologic and pharmacokinetic studies.

PKCζ is tyrosine phosphorylated by EGF and contributes to EGF-induced activation of ERK in Mef cells. PKCζ is tyrosine phosphorylated by EGF and contributes.

SAHA blocks IR-induced increase of RAD51 protein in MM cells.

Posttranslational phosphorylation of p53 by platinum drugs in ovarian tumor cells. Posttranslational phosphorylation of p53 by platinum drugs in ovarian.

RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.

I3C reduces the level of Cdc25A protein in breast cancer cells.

Volume 5, Issue 6, Pages (December 2015)

Presentation transcript:

HCT-15 HT-29 * Figure S1. Oxaliplatin treatment increases CD44high subpopulations in both HCT-15 and HT-29 cells. Flow cytometry was applied to measure the percentages of CD44high in HCT-15 and HT-29 cells after they were treated without or with the indicated concentrations of oxaliplatin for 48 hrs. (CD44high subpopulation was defined as the ones whose surface CD44 levels were equal to or higher than those of the top 10% of CD44+ population of cells treated with vehicle). *P < 0.05 by Student’s test

Cell viability (%) Oxa (mM) Figure S2. The toxic effects of oxaliplatin in HT-29 and r29 cells. MTT assays were performed to measure the viability of parental HT-29 (WT) and r29 cells after they were treated with different concentrations of oxaliplatin for 48 hrs.

A HCT-15 HT-29 B HCT-15 HT-29 Figure S3. MG132 and Carfilzomib can not reduce the stem cell subpopulations in HCT-15 and HT-29 cells. HCT-15 and HT-29 cells were treated with dimethyl sulfoxide (DMSO as a vehicle control, Veh) or the indicated concentrations of MG132 (A) or Carfilzomib (B) for 48 hrs before flow cytometry was used to measure the percentages of CD133+CD44+ subpopulations (Number in each of the upper-right quadrant).

A B Figure S4. Protein levels of various stemness markers in HCT-15 and HT-29 cells before and after MG132 and carfilzomib treatments. Total lysates prepared from HCT-15 and HT-29 cells after being treated without or with different doses of MG132 (A) and carfilzomib (Car, B) for 48 hrs were subjected to Western blot analyses using antibodies against CD44, ALDH1, Oct4, Nanog, Bmi1 and Twist, respectively, as probes. Tubulin signal was served as a loading control.